The MDC Mission

The Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) carries out basic biomedical research with the aim of understanding the molecular basis of health and disease, and translating these findings as quickly as possible into clinical application. The research involves the diagnosis and treatment of diseases, as well as their prevention.

Research Highlights

Insulin-sensitive fat leads to obesity

SORLA is a protein that influences metabolism in adipose tissue. If there is too much of the molecule, fat cells become overly sensitive to insulin and break down less fat. This new link between SORLA and increases in body weight was discovered by MDC researchers. SORLA was previously known for its role in defending the brain against Alzheimer’s disease.


Personalized medicine: T cells fight cancer

In cancer, one of the body’s cells stops playing by the rules that govern the cell cycle and divides uncontrollably. This is often due to mutations that lead to errors in the mechanisms that control cell division. Several teams of scientists at the MDC and the Charité are working on a T-cell therapy that specifically […]


Further research highlights


Globalizing medical imaging

Lukas Winter, a postdoc in Thoralf Niendorf's lab, is activating the MRI community in an Open Source project to build instruments that will be affordable and accessible to people all over the world.


Sequencing on the move

After 7 years of service and research as head of BIMSB's Genomics Platform, Wei Chen sets off for a new challenge.


Yasuyuki Fujita: helping cells recognise bad neighbours

MDC alumnus and Professor Yasuyuki Fujita has good advice for budding scientists who want to establish their own group. In his research he investigates the interactions between cancer cells and their neighbouring cells, aiming to find a way to help healthy cells recognise tumour cells and kill them.


Further news on MDC Insights